BCM
Bayesian Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,931
| Closed | -$1.23M | – | 1123 |
|
|
2024
Q1 | $1.23M | Buy |
+2,931
| New | +$1.23M | 0.12% | 245 |
|
|
2023
Q2 | – | Sell |
-9,131
| Closed | -$2.88M | – | 1082 |
|
|
2023
Q1 | $2.88M | Buy |
+9,131
| New | +$2.88M | 0.36% | 74 |
|
|
2022
Q3 | – | Sell |
-1,831
| Closed | -$516K | – | 1039 |
|
|
2022
Q2 | $516K | Sell |
1,831
-7,869
| -81% | -$2.22M | 0.1% | 327 |
|
|
2022
Q1 | $2.53M | Buy |
9,700
+6,560
| +209% | +$1.71M | 0.38% | 41 |
|
|
2021
Q4 | $690K | Buy |
+3,140
| New | +$690K | 0.22% | 136 |
|
|
2021
Q1 | – | Sell |
-6,100
| Closed | -$1.44M | – | 704 |
|
|
2020
Q4 | $1.44M | Sell |
6,100
-5,222
| -46% | -$1.23M | 0.38% | 66 |
|
|
2020
Q3 | $3.08M | Buy |
+11,322
| New | +$3.08M | 0.75% | 17 |
|
|
2020
Q1 | – | Sell |
-5,800
| Closed | -$1.27M | – | 997 |
|
|
2019
Q4 | $1.27M | Buy |
5,800
+4,308
| +289% | +$943K | 0.22% | 139 |
|
|
2019
Q3 | $253K | Buy |
+1,492
| New | +$253K | 0.05% | 402 |
|
|
2018
Q3 | – | Sell |
-16,421
| Closed | -$2.79M | – | 812 |
|
|
2018
Q2 | $2.79M | Buy |
16,421
+13,839
| +536% | +$2.35M | 0.63% | 24 |
|
|
2018
Q1 | $421K | Buy |
+2,582
| New | +$421K | 0.11% | 307 |
|
|
2017
Q1 | – | Sell |
-9,253
| Closed | -$682K | – | 708 |
|
|
2016
Q4 | $682K | Buy |
+9,253
| New | +$682K | 0.17% | 230 |
|